| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications
|
Moens, Thomas G
|
|
|
24 |
2 |
p. 166-178
|
artikel
|
| 2 |
Anticoagulation for patients with device-detected atrial fibrillation and a history of stroke
|
Sposato, Luciano A
|
|
|
24 |
2 |
p. 92-94
|
artikel
|
| 3 |
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
|
Shoamanesh, Ashkan
|
|
|
24 |
2 |
p. 140-151
|
artikel
|
| 4 |
Correction to Lancet Neurol 2025; 24: 65–76
|
|
|
|
24 |
2 |
p. e2
|
artikel
|
| 5 |
Creative neurorehabilitation: the art of intervention
|
Morgan, Jules
|
|
|
24 |
2 |
p. 102-103
|
artikel
|
| 6 |
Elevating the wellbeing of neurologists
|
Busis, Neil A
|
|
|
24 |
2 |
p. 99
|
artikel
|
| 7 |
EU regulatory horizons for Alzheimer's disease
|
Blanquie, Oriane
|
|
|
24 |
2 |
p. 96-97
|
artikel
|
| 8 |
From stroke awareness to stroke action awareness
|
Liu, Renyu
|
|
|
24 |
2 |
p. 96
|
artikel
|
| 9 |
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial
|
Coleman, Kristy K L
|
|
|
24 |
2 |
p. 128-139
|
artikel
|
| 10 |
Nanna Brix Finnerup: integrity and openness to alternatives
|
Venkatesan, Priya
|
|
|
24 |
2 |
p. 98
|
artikel
|
| 11 |
Pengfei Yang
|
|
|
|
24 |
2 |
p. 99
|
artikel
|
| 12 |
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
|
Antozzi, Carlo
|
|
|
24 |
2 |
p. 105-116
|
artikel
|
| 13 |
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
|
Habib, Ali A
|
|
|
24 |
2 |
p. 117-127
|
artikel
|
| 14 |
Should the preclinical stage of Alzheimer's disease be disclosed?
|
Masters, Colin L
|
|
|
24 |
2 |
p. 94-95
|
artikel
|
| 15 |
Standing in Cushing's shadow
|
Stirrups, Robert
|
|
|
24 |
2 |
p. 104
|
artikel
|
| 16 |
Therapies for myasthenia gravis: FcRn inhibition and beyond
|
Schneider-Gold, Christiane
|
|
|
24 |
2 |
p. 88-89
|
artikel
|
| 17 |
The role of IL-6 blockers in myasthenia gravis
|
Waheed, Waqar
|
|
|
24 |
2 |
p. 89-90
|
artikel
|
| 18 |
Transforming amyotrophic lateral sclerosis into a liveable disease
|
Feldman, Eva L
|
|
|
24 |
2 |
p. 100-101
|
artikel
|
| 19 |
Traumatic brain injury in older adults: a neglected challenge
|
The Lancet Neurology,
|
|
|
24 |
2 |
p. 87
|
artikel
|
| 20 |
Treating apathy in frontotemporal dementia
|
Irish, Muireann
|
|
|
24 |
2 |
p. 90-92
|
artikel
|
| 21 |
Unique considerations in the assessment and management of traumatic brain injury in older adults
|
Depreitere, Bart
|
|
|
24 |
2 |
p. 152-165
|
artikel
|
Tijdschrift beschrijving